Qilian International Holding Group Limited

Qilian International Holding Group Limited

QLI
Qilian International Holding Group LimitedUS flagNASDAQ Global Market
Qilian International Holding Group Limited
QLI
(NASDAQ Global Market)

Recent

price

5.41

P/E

ratio

-4.918181818181818

div

yld

- -

ROIC.AI

Capital Structure

in mil. unless spec.
Working Capital

in mil. unless spec.
Growth Rates

in mil. unless spec.
Quarterly Revenue

in mil. unless spec.
Quarterly Earnings Per Share

in mil. unless spec.
Quarterly Dividends Per Share

in mil. unless spec.
Business
Qilian International Holding Group Limited engages in the research, development, and production of active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company offers licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions. It also provides Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetracycline APIs for pharmaceutical companies to manufacture medications. In addition, the company offers TCMD products, such as Ahan antibacterial paste to treat refractory chronic skin diseases; heparin products, including heparin sodium preparations for pharmaceutical companies to produce medications for cardiovascular diseases, cerebrovascular diseases, and hemodialysis; and Zhu Xiaochang sausage casings, which are natural food products for culinary application. Further, it provides Xiongguan organic fertilizers to improve crop yield and soil's chemical properties and reduce soil compaction; and Xiongguan organic-inorganic compound fertilizers to increased plant growth. The company was incorporated in 2019 and is based in Jiuquan, the People's Republic of China.

Company News

  • Qilian International Holding Group Ltd. Announces Trading Ticker Symbol to "BGM"

  • Qilian International Holding Group Ltd Regained Compliance with Nasdaq's Minimum Bid Price Rule

  • Qilian International Holding Group Limited Announces 1 for 5 Reverse Share Split

  • Qilian International plans to adjust industrial investment

  • Qilian International Holding Group Receives 180-day Extension from Nasdaq to Meet Minimum Bid Price Rule

  • Qilian International Holding Group Ltd Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

  • Qilian International Holding Group Limited Reports Financial Results for the First Six Months of Fiscal Year 2021

  • Qilian International Holding Group Limited Signs Agreement with District Government, Settling the Project in Local High-tech Zone

  • Qilian International Holding Group Limited Enters into Investment Agreement for Pig By-product Processing Project in Chongqing

  • QLI Stock Price Increased Over 10% Pre-Market: Why It Happened

  • Qilian International Holding Group Limited Reports Fiscal Year 2020 Financial Results

  • Qilian International Holding Group Limited to Triple Organic Fertilizer Production Capacity by March 2021

  • U.S. IPO Week Ahead: Bumble's Billion-Dollar Deal Leads A Buzzy 11 IPO Week

  • Qilian International Holding Group Limited Announces Closing of Initial Public Offering